These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9824427)

  • 1. Drug update: letrozole: A new aromatase inhibitor for metastatic breast cancer.
    Mays-Holland T
    Cancer Pract; 1998; 6(6):349-52. PubMed ID: 9824427
    [No Abstract]   [Full Text] [Related]  

  • 2. Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.
    Lipton A; Demers LM; Harvey HA; Kambic KB; Grossberg H; Brady C; Adlercruetz H; Trunet PF; Santen RJ
    Cancer; 1995 Apr; 75(8):2132-8. PubMed ID: 7697604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critics question price of success in halted clinical trial of aromatase inhibitor letrozole.
    Twombly R
    J Natl Cancer Inst; 2003 Dec; 95(23):1738-9. PubMed ID: 14652229
    [No Abstract]   [Full Text] [Related]  

  • 4. Beating breast cancer.
    Fricker J
    Nurs Stand; 2004 Aug 11-17; 18(48):15. PubMed ID: 15366393
    [No Abstract]   [Full Text] [Related]  

  • 5. Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.
    Altundag K; Altundag O
    J Clin Oncol; 2003 Dec; 21(24):4656; author reply 4657. PubMed ID: 14673060
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen.
    Lipton A; Ali SM; Leitzel K; Demers L; Harvey HA; Chaudri-Ross HA; Brady C; Wyld P; Carney W
    J Clin Oncol; 2003 May; 21(10):1967-72. PubMed ID: 12743150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aromatase inhibitors for breast cancer.
    Drug Ther Bull; 1997 Jul; 35(7):55-6. PubMed ID: 9282426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letrozole in breast cancer.
    Hietanen P; Mäkelä M
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971057
    [No Abstract]   [Full Text] [Related]  

  • 9. Letrozole in breast cancer.
    Harris SR
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971059
    [No Abstract]   [Full Text] [Related]  

  • 10. The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
    Chen WY; Manson JE
    Womens Health Issues; 2004; 14(1):7-10. PubMed ID: 15001182
    [No Abstract]   [Full Text] [Related]  

  • 11. Pivotal trials of letrozole: a new aromatase inhibitor.
    Smith IE
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):41-4. PubMed ID: 9556791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole in breast cancer.
    Buzdar AU
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14960751
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer studies challenge tamoxifen therapy.
    Timms B
    Lancet Oncol; 2000 Nov; 1():132. PubMed ID: 11905647
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-tumor effects of letrozole.
    Miller WR; Anderson TJ; Dixon JM
    Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complete remission obtained with letrozole in a man with metastatic breast cancer].
    Italiano A; Largillier R; Marcy PY; Foa C; Ferrero JM; Hartmann MT; Namer M
    Rev Med Interne; 2004 Apr; 25(4):323-4. PubMed ID: 15050804
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous leukocytoclastic vasculitis associated with letrozole.
    Digklia A; Tzika E; Voutsadakis IA
    J Oncol Pharm Pract; 2014 Apr; 20(2):146-8. PubMed ID: 23676512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letrozole.
    Dellapasqua S; Colleoni M
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):251-9. PubMed ID: 20095792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole in breast cancer.
    Shahab N
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
    [No Abstract]   [Full Text] [Related]  

  • 19. Aromatase inhibitors and inactivators in breast cancer.
    Lønning PE
    BMJ; 2001 Oct; 323(7318):880-1. PubMed ID: 11668120
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol.
    Messori A; Cattel F; Trippoli S; Vaiani M
    Anticancer Drugs; 2000 Oct; 11(9):701-6. PubMed ID: 11129731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.